Treatment of primary CNS lymphoma with methotrexate and deferred radiotherapy: a report of NABTT 96-07.

Batchelor, Tracy; Carson, Kathryn; O'Neill, Alison; Grossman, Stuart A; Alavi, Jane; New, Pamela; Hochberg, Fred; Priet, Regina

Batchelor, Tracy; Carson, Kathryn; O'Neill, Alison; Grossman, Stuart A; Alavi, Jane; New, Pamela; Hochberg, Fred; Priet, Regina.

Affiliation

Batchelor T; Massachusetts General Hospital, Boston, MA, USA. jfisher@jhmi.edu

J Clin Oncol ; 21(6): 1044-9, 2003 Mar 15.

Article in En | MEDLINE | ID: mdl-12637469

Subject(s)

Antimetabolites, Antineoplastic/therapeutic use; Brain Neoplasms/drug therapy; Brain Neoplasms/radiotherapy; Lymphoma/drug therapy; Lymphoma/radiotherapy; Methotrexate/therapeutic use; Adult; Aged; Brain Neoplasms/mortality; Brain Neoplasms/pathology; Chemotherapy, Adjuvant; Disease-Free Survival; Female; Humans; Lymphoma/mortality; Lymphoma/pathology; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Methotrexate / Lymphoma / Antimetabolites, Antineoplastic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2003 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links